Clinical Trials Browser

Phase 3 × Neoplasms × abiraterone × Clear all

NCT06691984 2026-05-15

Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)

Phase 3 Active not recruiting

Neoplasms, Prostatic Neoplasms